Home › Companies › Fulgent Genetics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Fulgent Genetics, Inc.’s Form 8-K, filed 2026-05-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Fulgent Genetics, Inc. in the interactive database Compare manager voting policies
These tallies are Fulgent Genetics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Ming Hsieh | 21,979,668 | -- | -- | 276,275 | 2,323,053 | Majority: yes |
| Elect Director: Linda Dong | 16,836,781 | -- | -- | 5,419,162 | 2,323,053 | Majority: yes |
| Elect Director: Michael Nohaile, Ph.D. | 17,258,629 | -- | -- | 4,997,314 | 2,323,053 | Majority: yes |
| Elect Director: Regina Groves | 16,240,666 | -- | -- | 6,015,277 | 2,323,053 | Majority: yes |
| Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | 24,470,414 | 87,192 | 21,390 | -- | -- | Majority: yes |
| Proposal 3 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | 19,800,226 | 2,410,239 | 45,478 | -- | 2,323,053 | Majority: yes |
| Proposal 4 Approval of the Company's 2026 Equity Incentive Plan. | 18,693,758 | 3,513,983 | 48,202 | -- | 2,323,053 | Majority: yes |
Source: Fulgent Genetics, Inc., Form 8-K, filed with the SEC on 2026-05-14 — read the filing on EDGAR.
Each item below shows how the 209 asset managers that disclosed a Fulgent Genetics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Fulgent Genetics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Proposal 3 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.”): 19,800,226 for, 2,410,239 against, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 70% for, 8% against (78% of the company cast a for/against vote).
The 180 asset managers below cast 90% of the shares they voted on this item FOR (9,416,006 for, 1,028,027 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,262,254 | 5,585 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,289,000 | 0 | 0 | 0 | For |
| Vanguard | 1,250,061 | 3 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 752,353 | 0 | 0 | 0 | For |
| Fidelity | 581,214 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 556,681 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 508,854 | 0 | 0 | Against |
| State Street | 395,588 | 3,965 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 179,433 | 0 | 0 | 0 | For |
| Dimensional | 0 | 166,349 | 0 | 0 | Against |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 165,521 | 0 | 0 | 0 | For |
| Peapod Lane Capital LLC | 145,474 | 0 | 0 | 0 | For |
| Nuveen | 145,114 | 0 | 0 | 0 | For |
| TIAA | 144,282 | 0 | 0 | 0 | For |
| Two Sigma | 134,066 | 0 | 0 | 0 | For |
| Northern Trust | 129,877 | 2,372 | 0 | 0 | For |
| PIMCO | 124,279 | 0 | 0 | 0 | For |
| American Century | 108,071 | 0 | 0 | 0 | For |
| Portolan Capital Management, LLC | 106,642 | 0 | 0 | 0 | For |
| UBS | 0 | 97,121 | 0 | 0 | Against |
| Nationwide | 76,461 | 0 | 0 | 0 | For |
| LEVIN CAPITAL STRATEGIES, L.P. | 60,496 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 46 | 53,735 | 0 | 0 | Against |
| T. Rowe Price | 48,544 | 0 | 0 | 0 | For |
| GuideStone | 45,160 | 0 | 0 | 0 | For |
Showing the 25 largest of 180 asset managers. See all 180 in the interactive database.
Combines 2 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Linda Dong”): 16,836,781 for, 5,419,162 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 59% for, 19% withheld (78% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (2,384,737 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 1,167,126 | 0 | Abstain |
| Vanguard | 1,096,039 | 0 | 8 | 0 | For |
| Fidelity | 484,877 | 0 | 95,305 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 508,854 | 0 | Abstain |
| Charles Schwab | 405,573 | 0 | 0 | 0 | For |
| TIAA | 144,282 | 0 | 0 | 0 | For |
| PIMCO | 0 | 0 | 124,279 | 0 | Abstain |
| Nationwide | 0 | 0 | 76,461 | 0 | Abstain |
| Dimensional | 71,453 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 53,949 | 0 | Abstain |
| Federated Hermes | 0 | 0 | 49,207 | 0 | Abstain |
| GuideStone | 0 | 0 | 45,160 | 0 | Abstain |
| Equitable | 0 | 0 | 42,001 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 34,731 | 0 | Abstain |
| Lincoln Financial | 18,423 | 0 | 13,415 | 0 | For |
| JPMorgan | 0 | 0 | 31,219 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 27,554 | 0 | Abstain |
| State Street | 27,316 | 0 | 62 | 0 | For |
| Russell Investments | 23,479 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,253 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 23,208 | 0 | Abstain |
| NORTHERN LIGHTS FUND TRUST III | 19,250 | 0 | 0 | 0 | For |
| Global X | 18,571 | 0 | 0 | 0 | For |
| Invesco | 16,941 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 13,986 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Michael Nohaile, Ph.D.”): 17,258,629 for, 4,997,314 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 61% for, 18% withheld (78% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (2,688,240 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 850,102 | 0 | 317,024 | 0 | For |
| Vanguard | 1,093,506 | 0 | 2,541 | 0 | For |
| Fidelity | 493,465 | 0 | 86,717 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 508,854 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 405,573 | 0 | Abstain |
| TIAA | 0 | 0 | 144,282 | 0 | Abstain |
| PIMCO | 0 | 0 | 124,279 | 0 | Abstain |
| Nationwide | 577 | 0 | 75,884 | 0 | Abstain |
| Dimensional | 71,453 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 53,949 | 0 | Abstain |
| Federated Hermes | 0 | 0 | 49,207 | 0 | Abstain |
| GuideStone | 0 | 0 | 45,160 | 0 | Abstain |
| Equitable | 29,541 | 0 | 12,460 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,731 | 0 | 0 | 0 | For |
| Lincoln Financial | 18,423 | 0 | 13,415 | 0 | For |
| JPMorgan | 0 | 0 | 31,219 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 27,554 | 0 | Abstain |
| State Street | 27,313 | 0 | 65 | 0 | For |
| Russell Investments | 0 | 0 | 23,479 | 0 | Abstain |
| Goldman Sachs | 23,253 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 23,208 | 0 | Abstain |
| NORTHERN LIGHTS FUND TRUST III | 0 | 0 | 19,250 | 0 | Abstain |
| Global X | 0 | 0 | 18,571 | 0 | Abstain |
| Invesco | 0 | 0 | 16,941 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 13,986 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Ming Hsieh”): 21,979,668 for, 276,275 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 77% for, 1.0% withheld (78% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (4,749,388 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,167,126 | 0 | 0 | 0 | For |
| Vanguard | 1,096,047 | 0 | 0 | 0 | For |
| Fidelity | 580,182 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 508,854 | 0 | 0 | 0 | For |
| Charles Schwab | 405,573 | 0 | 0 | 0 | For |
| TIAA | 144,282 | 0 | 0 | 0 | For |
| PIMCO | 124,279 | 0 | 0 | 0 | For |
| Nationwide | 76,461 | 0 | 0 | 0 | For |
| Dimensional | 71,453 | 0 | 0 | 0 | For |
| American Century | 53,949 | 0 | 0 | 0 | For |
| Federated Hermes | 49,207 | 0 | 0 | 0 | For |
| GuideStone | 45,160 | 0 | 0 | 0 | For |
| Equitable | 29,541 | 0 | 12,460 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,731 | 0 | 0 | 0 | For |
| Lincoln Financial | 31,838 | 0 | 0 | 0 | For |
| JPMorgan | 31,219 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 27,554 | 0 | 0 | 0 | For |
| State Street | 27,378 | 0 | 0 | 0 | For |
| Russell Investments | 23,479 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,253 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 23,208 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 19,250 | 0 | 0 | 0 | For |
| Global X | 18,571 | 0 | 0 | 0 | For |
| Invesco | 16,941 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,986 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 2 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Elect Director: Regina Groves”): 16,240,666 for, 6,015,277 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 57% for, 21% withheld (78% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (2,180,868 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 1,167,126 | 0 | Abstain |
| Vanguard | 1,096,038 | 0 | 9 | 0 | For |
| Fidelity | 484,877 | 0 | 95,305 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 508,854 | 0 | Abstain |
| Charles Schwab | 405,573 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 144,282 | 0 | Abstain |
| PIMCO | 0 | 0 | 124,279 | 0 | Abstain |
| Nationwide | 0 | 0 | 76,461 | 0 | Abstain |
| Dimensional | 71,453 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 53,949 | 0 | Abstain |
| Federated Hermes | 0 | 0 | 49,207 | 0 | Abstain |
| GuideStone | 0 | 0 | 45,160 | 0 | Abstain |
| Equitable | 0 | 0 | 42,001 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 34,731 | 0 | Abstain |
| Lincoln Financial | 4,023 | 0 | 27,815 | 0 | Abstain |
| JPMorgan | 0 | 0 | 31,219 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 27,554 | 0 | Abstain |
| State Street | 29 | 0 | 27,349 | 0 | Abstain |
| Russell Investments | 23,479 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,253 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 23,208 | 0 | Abstain |
| NORTHERN LIGHTS FUND TRUST III | 19,250 | 0 | 0 | 0 | For |
| Global X | 18,571 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 16,941 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 13,986 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 2 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Proposal 4 Approval of the Company's 2026 Equity Incentive Plan.”): 18,693,758 for, 3,513,983 against, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 66% for, 12% against (78% of the company cast a for/against vote).
The 55 asset managers below cast 84% of the shares they voted on this item FOR (4,020,684 for, 745,849 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,167,126 | 0 | 0 | 0 | For |
| Vanguard | 1,094,325 | 1,722 | 0 | 0 | For |
| Fidelity | 493,465 | 86,717 | 0 | 0 | For |
| Columbia Threadneedle | 508,854 | 0 | 0 | 0 | For |
| Charles Schwab | 405,573 | 0 | 0 | 0 | For |
| TIAA | 0 | 144,282 | 0 | 0 | Against |
| PIMCO | 0 | 124,279 | 0 | 0 | Against |
| Nationwide | 577 | 75,884 | 0 | 0 | Against |
| Dimensional | 0 | 71,453 | 0 | 0 | Against |
| American Century | 53,949 | 0 | 0 | 0 | For |
| Federated Hermes | 49,207 | 0 | 0 | 0 | For |
| GuideStone | 0 | 45,160 | 0 | 0 | Against |
| Equitable | 29,541 | 12,460 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,731 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 31,838 | 0 | 0 | Against |
| JPMorgan | 31,219 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 27,554 | 0 | 0 | Against |
| State Street | 26 | 27,352 | 0 | 0 | Against |
| Russell Investments | 23,479 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,253 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 23,208 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 0 | 19,250 | 0 | 0 | Against |
| Global X | 18,571 | 0 | 0 | 0 | For |
| Invesco | 16,941 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 13,986 | 0 | 0 | Against |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Proposal 2 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 24,470,414 for, 87,192 against, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 86% for, 0.4% against (86% of the company cast a for/against vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (4,763,527 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,167,126 | 0 | 0 | 0 | For |
| Vanguard | 1,096,047 | 0 | 0 | 0 | For |
| Fidelity | 580,182 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 508,854 | 0 | 0 | 0 | For |
| Charles Schwab | 405,573 | 0 | 0 | 0 | For |
| TIAA | 144,282 | 0 | 0 | 0 | For |
| PIMCO | 124,279 | 0 | 0 | 0 | For |
| Nationwide | 76,461 | 0 | 0 | 0 | For |
| Dimensional | 71,453 | 0 | 0 | 0 | For |
| American Century | 53,949 | 0 | 0 | 0 | For |
| Federated Hermes | 49,207 | 0 | 0 | 0 | For |
| GuideStone | 45,160 | 0 | 0 | 0 | For |
| Equitable | 42,001 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 34,731 | 0 | 0 | 0 | For |
| Lincoln Financial | 31,838 | 0 | 0 | 0 | For |
| JPMorgan | 31,219 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 27,554 | 0 | 0 | 0 | For |
| State Street | 27,378 | 0 | 0 | 0 | For |
| Russell Investments | 23,479 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,253 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 23,208 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 19,250 | 0 | 0 | 0 | For |
| Global X | 18,571 | 0 | 0 | 0 | For |
| Invesco | 16,941 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,986 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
89% Majority: yes · of votes cast
Fulgent Genetics, Inc.’s own tally for this item (“Proposal 3 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.”): 19,800,226 for, 2,410,239 against, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,400,623 outstanding shares: 70% for, 8% against (78% of the company cast a for/against vote).
The 30 asset managers below cast 55% of the shares they voted on this item FOR (928,634 for, 756,930 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 811,210 | 0 | 0 | 0 | For |
| Invenomic Capital Management LP | 0 | 352,055 | 0 | 0 | Against |
| TCW GROUP INC | 0 | 126,600 | 0 | 0 | Against |
| Russell Investments | 0 | 102,122 | 0 | 0 | Against |
| Federated Hermes | 98,414 | 0 | 0 | 0 | For |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0 | 78,267 | 0 | 0 | Against |
| Global X | 0 | 18,571 | 0 | 0 | Against |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 17,704 | 0 | 0 | 0 | For |
| Linden Thomas Advisory Services, LLC | 0 | 11,815 | 0 | 0 | Against |
| MACKENZIE FINANCIAL CORP | 0 | 10,730 | 0 | 0 | Against |
| BANK OF AMERICA NA | 0 | 8,737 | 0 | 0 | Against |
| SEI | 0 | 8,418 | 0 | 0 | Against |
| WASHINGTON STATE INVESTMENT BOARD | 0 | 8,246 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 8,173 | 0 | 0 | Against |
| Universal-Investment-Gesellschaft mbH | 0 | 8,010 | 0 | 0 | Against |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 5,879 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 3,395 | 0 | 0 | Against |
| Vanguard | 1,291 | 816 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 0 | 1,603 | 0 | 0 | Against |
| NEW COVENANT FUNDS | 0 | 853 | 0 | 0 | Against |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 0 | 706 | 0 | 0 | Against |
| Neuberger Berman | 0 | 526 | 0 | 0 | Against |
| NISA INVESTMENT ADVISORS, LLC | 0 | 410 | 0 | 0 | Against |
| ALLSTATE INVESTMENTS LLC | 0 | 370 | 0 | 0 | Against |
| YOUSIF CAPITAL MANAGEMENT, LLC | 0 | 216 | 0 | 0 | Against |
Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.
Ranked by the number of Fulgent Genetics, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 28,400,623 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 7.99% |
| 2 | RTW INVESTMENTS, LP | 4.54% |
| 3 | Vanguard | 4.40% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 2.65% |
| 5 | Fidelity | 2.05% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.96% |
| 7 | Columbia Threadneedle | 1.79% |
| 8 | State Street | 1.41% |
| 9 | Connor, Clark & Lunn Investment Management Ltd. | 0.63% |
| 10 | Dimensional | 0.59% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Ming Hsieh | 31.24% | 13D |
| BlackRock | 9.77% | 13F |
| Barclays PLC | 8.23% | DEF14A |
| Vanguard Group | 4.44% | 13F |
| Hanlin Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. | 3.28% | DEF14A |
| Integrated Core Strategies (US) LLC | 3.23% | 13G |
| Dimensional Fund Advisors | 2.36% | 13F |
| Geode Capital | 2.06% | 13F |
| State Street | 1.86% | 13F |
| D.E. Shaw | 1.71% | 13F |
Percentages above are of 28,400,623 shares outstanding, as reported by Fulgent Genetics, Inc. on its Form 10-Q dated 2026-04-27 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Fulgent Genetics, Inc.’s 10-Q dated 2026-04-27. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Fulgent Genetics, Inc.'s shareholder meeting held 2026-05-14, in the 2025-2026 proxy season, 209 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,444 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, compensation awarded to the Company's named executive… — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Fulgent Genetics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-14.
Fulgent Genetics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).